Digital Therapeutics Market to Reach $23.56 Billion, Globally, by 2030 at 20.6% CAGR: Allied Market Research

Rise in adoption of smartphones and tablets coupled with several healthcare apps, increase in need to control healthcare costs, and surge in incidences of chronic diseases drive the growth of the global digital therapeutics market.

PORTLAND, Ore., Dec. 6, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Digital Therapeutics Market by Application (Diabetes, Obesity, Cardio Vascular Diseases (CVD), Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders, and Others), Product Type (Software, and Devices), and Sales Channel (Business-to-Business and Business-to-Consumers): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global digital therapeutics industry was estimated at $3.53 billion in 2020, and is anticipated to hit $23.56 billion by 2030, registering a CAGR of 20.6% from 2021 to 2028.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/2117

Drivers, restraints, and opportunities-

Rise in adoption of smartphones and tablets coupled with several healthcare apps, increase in need to control healthcare costs, and surge in incidences of chronic diseases drive the growth of the global digital therapeutics market. On the other hand, lack of awareness regarding digital therapeutics in developing countries restrains the growth to some extent. However, extensive product pipeline is expected to create lucrative opportunities in the industry.

COVID-19 Impact Analysis on Digital Therapeutics Market-

• Rise of digital health impacted the global digital therapeutics market positively.
• This trend is most likely to continue post pandemic as well.

Get detailed COVID-19 impact analysis on the Digital Therapeutics Market- https://www.alliedmarketresearch.com/request-for-customization/2117?reqfor=covid

The diabetes segment to retain the lion's share-

On the basis of application, the diabetes segment held the major share in 2020, garnering nearly one-fourth of the global digital therapeutics market. This is due to increase in the prevalence of chronic disease such as obesity, cardiovascular disease and among others. The central nervous system diseases segment, however, is expected to cite the fastest CAGR of 24.2% throughout the forecast period.

The software segment to dominate by 2028-

On the basis of product type, the software segment contributed to the lion's share in 2020, holding more than two-thirds of the global digital therapeutics market. The same segment is also projected to manifest the fastest CAGR of 21.0% from 2021 to 2028. Increase in prevalence of chronic diseases along with rise in elderly population are the key factors driving the segment growth.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/2117

North America held the major share in 2020-

By region, the market across North America, dominated in 2020, garnering nearly half of the global digital therapeutics market, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region.  Europe, on the other hand, is expected to cite the fastest CAGR of 22.7% throughout the forecast period. Improvement in R&D facilities and rapidly developing economic conditions in the province propel the market growth.

Key Players in the industry

• Akili Interactive Labs, Inc.
• Click Therapeutics Inc.
• Fitbit Inc. (Twine Health Inc.)
• Happify Inc.
• Kaia Health
• Livongo Health Inc.
• Medtronic Plc.
• Omada Health Inc.
• Pear Therapeutics Inc.
• Welldoc Inc.
• Mango Health Inc.
• Proteus Digital Health Inc.
• 2MORROW Inc.
• Resmed Inc. (Propeller Health)
• Voluntis Inc.

Official Press Release: https://www.alliedmarketresearch.com/press-release/digital-therapeutics-market.html

Similar Research Reports for Information, Communication and Technology:

Paclitaxel-eluting Stent Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Hysteroscope Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Interventional Oncology Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Intraosseous Infusion Device Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Orthopedic Consumables Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com  
Web: https://www.alliedmarketresearch.com   
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg